8/2/2025PD‑L1×VEGF Bispecific from ImmuneOnco Shows Strong Efficacy in China...

8/1/2025Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...

8/1/2025Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...

7/31/2025China Sees Surge in Drug Applications: 24 New Therapies Filed with NMP...

7/31/2025Lee’s Subsidiary Wins Approval of Socazolimab for ES‑SCLC in China

7/31/2025Alphamab's JSKN003 Wins Orphan and BTD Designations in Two Major Marke...

7/30/2025China Approves Domestic CD19 CAR-T Therapy Hengkailai

7/30/2025SPH Biothera Receives NMPA Clearance for CAR-T Therapy Targeting Refra...

7/29/2025Pfizer Launches Landmark Pneumococcal Vaccine Trial in China, Pioneeri...

7/29/2025Innovent Wins NMPA Clearance for IBI363 in Two New Cancer Trials

7/29/2025LENZ Moves Toward Approval in China with LNZ100 Submission

7/29/2025Bayer Files HER2+ Lung Cancer Drug in China

7/28/2025Antengene's XPOVIO® Wins Third Approval in China for Multiple Myeloma

7/28/2025China Medical System Gains NMPA Acceptance for Alzheimer's Drug ZUNVEY...

7/28/2025Pierre Fabre Scores China Approval for Braftovi + Cetuximab in BRAF V6...

7/28/2025TargetRx Showcases Breakthrough Allosteric BCR::ABL1 Inhibitor for Res...

7/28/2025China Approves BMS's Opdivo + Yervoy Combo for PD-L1 Positive mNSCLC

7/28/2025SystImmune Files First ARC IND as ADC Pipeline Hits Double Digits

7/26/2025China Leads Global Expansion in Clinical Trial Volume in Q2 2025: Glob...

7/25/2025Yangtze River Pharma's Tunodafil Wins NMPA Nod

7/25/2025Eisai's Lenvatinib Secures NMPA Approval in China

7/25/2025AusperBio Advances AHB‑137 to Phase 3 After Green Light from China NM...

7/24/2025Kelun-Biotech Initiates Phase I Trial of SKB107

7/24/2025Cascade Pharma's CS0159 Wins FDA Breakthrough For PBC

7/23/2025China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals

7/23/2025DualityBio's DB‑1310 Earns FDA Fast‑Track for EGFR‑Mutated Lung Can...

7/23/2025Qilu Initiates Global Phase III Trial of QLS31905 for Pancreatic Cance...

7/23/2025Kelun‑Biotech Launches Phase I Trial of SKB107 in China to Tackle Bon...

7/22/2025Livzon's Dual Inhibitor LZM‑012 Positive in Global Phase III Psoriasi...

7/22/2025Cloudbreak Pharma Reports Positive Phase 2 Outcomes for CBT‑004

Page:2/18 Total number of articles:534: [First][<<] [1] [2] [3] [4] [5] [>>] [End]